Found 6 matching trials
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations
PHASE3To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) exte...
Location
Xenoscience, Inc. (102)
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations
PHASE3The purpose of this study is to evaluate the long-term safety and clinical ...
Location
Xenoscience, Inc (102)
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
PHASE4The purpose of this study is to evaluate the effect of IPX203 (Crexont®) - ...
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
PHASE4The primary purpose of this study is to evaluate efficacy and safety of CRE...
Location
Barrow Neurological Institute
A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
PHASE2Primary Objective:
To compare the pharmacokinetics (PK) of single and mult...
A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
PHASE2This is a randomized, open-label, rater-blinded, multicenter, 3-treatment, ...
Location
Muhammad Ali Movement Disorder Center (MAMDC)